IDEX Stock: Sluggish Growth, Overvalued? | Business and Finance News

IDEX’s stock trades around $223, outperforming the S&P 500 over six months but showing sluggish organic growth and declining profitability. Core revenue growth sits at just 1.4% annually, while EPS growth lags even further at 1.2%, indicating decreasing efficiency. ROIC is falling, signaling the company may be running out of high-return investment opportunities. Trading at 25.7x forward earnings, it’s not a bad buy for risk-takers—but better opportunities exist elsewhere. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0a27cab088cad68f